Introduction
The pool of data on the true functions of AP-1 proteins in brain physiology, regeneration and degeneration is limited, in spite of innumerable publications reporting on the expression of AP-1 mRNAs and proteins in the nervous system and neural cells under physiological and pathological conditions. This insight is complicated by the capacity of AP-1 proteins to exert functionally antagonizing functions. This chapter critically reviews ®ndings on the involvement of AP-1 proteins in degenerative and regenerative processes in the adult nervous system, and develops scenarios for the functional transition of AP-1 proteins from physiological-neuroprotective players to degenerative eectors. One issue deserves particular attention: In this review, the functions of c-Jun are predominantly set into the context of the c-Jun N-terminal kinases (JNK) which are considered as regulators of c-Jun activity. Recent data, however, are accumulating that c-Jun and even nuclear JNKs can exert independentdissociating functions. Thus, the interplay within the cJun/JNK-axis might undergo substantial revision in the future.
General considerations of AP-1 proteins in the brain

Aspects of transcriptional functions
Knock-out of the c-jun gene is lethal for the developing embryo (Hilberg et al., 1993; Jochum et al., this issue) , whereas inhibition of the N-terminal phosphorylation by exchange of the serine residues 63 and 73 for alanin (c-JunAA) does not interfere with the development of an apparently intact and fertile phenotype (Behrens et al., 1999) . Consequently, functional inactivation of c-Jun with preservation of its physical presence substantially diers from functional inactivation by physical absence: in contrast to the knock-out of c-jun, c-JunAA can still act as suppressor and antagonizing inhibitor of other transcription factors (TFs). Thus, for understanding AP-1 functions, we have to consider their elaborate transcriptional functions (see also Chinenov and Kerppola, in this issue). As with the majority of TFs, AP-1 proteins function in several ways:
(a) Induction of transcription. Regulated by their posttranslational modi®cations (mainly by phosphorylation), their partners for the formation of homoand/or heterodimers and scaold proteins, AP-1 proteins bind to regulatory DNA sequences (AP-1 and ATF/CRE-like consensus motifs) and activate the basal transcription machinery (Ferrell, 2000;  reviewed in detail by Herdegen and Leah, 1998 ; see also M Yaniv, in this issue). In the context of the transcriptional orchestration, the AP-1 proteins co-determine the time and the amount of gene transcription.
(b) Suppression of transcription. Transcriptional suppression can be achieved by transcription factor binding to regulatory DNA promoter sequences without activating of RNA-polymerase II complex. For the distinction of the transcriptional state (activating versus non-activating), it is mandatory to visualize the speci®c post-translational modi®cations which underly the activation of the RNA-polymerase II by individual TFs. Thus, the mere presence of nuclear TF/AP-1 proteins does not allow conclusions about the transcriptional state of TFs. (c) Modulation of transcription beyond the DNApolymerase interface. AP-1 proteins can associate with other TFs such as steroidhormone-complexes, and this association prevents the DNA binding of both partners (see chapters by P Herrlich, A Rao and H van Dam in this issue). (d) Non-transcriptional eects. The presence of mRNA and/or proteins of TFs including AP-1 proteins in neurons outside the nucleus suggest functions of TFs beyond transcriptional control. For example, Fra-1 and the 55 kDa c-Fos isoform are present in synaptosomes and synaptic plasma membrane fractions from rat cerebral cortex and hippocampus, from where they might be retransported into the nucleus (Paratcha et al., 2000) . FosB immunoreactivities were found in dendrites following kainic acid-induced seizures (Gass et al., 1993) and in the nucleolus following axotomy (Robinson, 1995) . ATF-2, which might be relevant for cJun mediated transcription , is transported along the axon-target axis apparently serving as an information shuttle between perikaryon and axonal-synaptic events.
Temporospatial expression in the brain
The AP-1 proteins substantially dier in their temporospatial expression patterns. The analysis of their distribution alleviates the understanding of their putative functions since the combinatory variety is limited by the individual expression. In theory, more than 20 dimers can be formed by heterodimerization of Fos and Jun proteins or homodimerization of Jun proteins without considering the splice variants; this number is furthermore enhanced when we regard the heterodimers with non-AP-1 proteins (summarized in Herdegen and Leah, 1998) . It may be helpful to roughly characterize the inducibility of the AP-1 proteins in the brain and their role in brain pathophysiology (for details see Herdegen and Leah, 1998) .
c-Jun Basal expression is detected in various compartments including dentate gyrus, motoneurons, peripheral neurons and nuclei of the autonomic nervous system. Following transynaptic stimulation, c-Jun shows a similar induction pattern as c-Fos and JunB. Stimulation by non-synaptic insults (i.e. transection of nerve ®bers) selectively induces c-Jun and, to a lesser extent also JunD, but not other AP-1 proteins . This selective injury-triggered induction might be mediated through cis-activation of the distal AP-1 sequence of the c-jun promoter by cJun .
JunB Almost absent under basal conditions, this Jun protein is mainly induced in neurons in a pattern and half-life very similar to the properties of c-Fos (Edelstein et al., 2000; Gass et al., 1993; Hata et al., 2000) . Following injury, induction of JunB and c-Fos might primarily be mediated by transynaptic neuronal excitation; whether the inducibility of the junB promoter by IL-6 and CNTF (Coer et al., 1995) is relevant for neuronal JunB expression, remains to be elucidated.
JunD Expressed in neurons and glial cells, JunD displays a wide basal expression in the majority of cells in the nervous system. Following transynaptic and non-synaptic stimulation, JunD expression is enhanced in a delayed but lasting fashion. The pattern of JunD expression following non-synaptic degenerative stimulation resembles that of c-Jun. Phosphorylation of JunD by JNKs, however, is only achieved following heterodimerization with c-Jun (Kallunki et al., 1996) .
c-Fos Due to its fast expression, c-Fos becomes detectable within 30 ± 35 min following the onset of an experimental stimulus from rather low or nondetectable basal expression. Its expression is rather transient, at least following termination of the primary inducing stimulus (Purkiss et al., 1993) . In case of parallel induction of JunB, the c-Fos proteins might prefer this Jun isoform to c-Jun. The inducibility of cFos declines with progressing age (Salehi et al., 1999) and this observation supports the notion that c-Fos expression widely re¯ects the cellular responsiveness at the transcriptional level.
FosB The evident characteristic of FosB expression is its widespread absence in the brain under basal conditions and its delayed but protracted expression following intentional stimulation (Gass et al., 1993) . In contrast to other AP-1 proteins, FosB immunoreactivity can display speci®c labeling of the nucleolus raising the question about its dimerization partner (Robinson, 1995) . Importantly, splicing of the fosB gene yields truncated DFosB proteins with a comparatively persistent half-life which can confer robust inhibition of AP-1 dependent transcription (Chen et al., 1997) . Knockout of the fosB gene dramatically aects the maternal behavior towards newborn pups, and FosB is involved in further physiological functions such as the circadian rhythm and the imprint of the addiction memory (Chen et al., 1997; Herdegen and Leah, 1998) .
Fra1, Fra2
The understanding of these AP-1 proteins is still handicapped by the insucient characterization of the generation and structure of the proteins, and there is only recent evidence that Fra isoforms derive from the fosB gene (Chen et al., 1997) . mRNA analysis demonstrated a lasting expression of these AP-1 members after transient stimuli indicating a particular role for memory formation. This notion is supported by presynaptic and dendritic localization of Fra-IR which changes following behavioral stimuli (Paratcha et al., 2000) . (Behrens et al., 1999) , but in parallel, apoptosis is also involved in the termination of microglial activity resembling the processes in immune cells (Raivich et al., 1999) . In consequence, inhibition of apoptosis ± one of the central aims of novel strategies for the treatment of neurodegenerative diseases ± could also counteract the termination of microglial activity with prodegenerative eects such as persistent phagocytosis and immune reactions.
(ii) AP-1 proteins are essential for cell cycle progression and are also involved in the dierentiation of cells (Hilberg et al., 1993; Leppa and Bohmann, 1999) . In consequence, expression of AP-1 proteins in non-neuronal cells such as astrocytes and meningeal cells in vivo might trigger fundamental physiological responses to injury which are inevitably blocked by AP-1 antagonization. (iii) An important group of AP-1 target genes comprises the matrix metalloproteinases which are involved in in¯ammatory processes as well as in structural guidance depending on the expressing cell type (Xu et al., 2001) . Inhibition of AP-1 expression (e.g. by antisenseoligonucleotides) negatively aects memory formation (Grimm et al., 1997) and physiological-adaptive processes such as synchronization of the endogenous clock (Wollnik et al., 1995) . It remains a major challenge to develop strategies for AP-1 inhibition which selectively block degenerative functions without aecting physiological functions. Thus, null mutation of c-fos attenuates phenotypes of pathological activity such as kindling development as well as physiological functions such as reorganization of mossy ®bers (Watanabe et al., 1996) .
The functional inhibition of AP-1 proteins (e.g. by antisense-or decoy-oligonucleotides, inhibition of their upstream activatory kinases) as a strategy for the treatment of neurodegenerative disorders demands the careful analysis of the physiological action of AP-1 proteins for the estimation of harmful side eects. Moreover, this analysis is the premise for answering the question to which extent neurodegenerative eects of AP-1 are pathologically enhanced physiological functions or due to qualitatively dierent properties such as binding of novel partners and the subsequent transcription of novel target genes.
Induction by degenerative stimuli: complex multifactorial responses
Degenerative processes evoked by one de®ned experimental stimulus, represent a mixture of primary and/ or secondary reactions with speci®c but sometimes overlapping programs triggered by dierential cascades of signal-transcription-coupling. Ischemia, for example, is ®rst of all an abrupt break of oxygenation and energy delivery; after some time, energy depletion, breakdown of membrane functions and rise of intracellular calcium occurs in parallel with transparency of the blood-brain-barrier, activation of microglia and release of cytokines from multiple cellular sources (reviewed by Lipton, 1999) . These processes run in parallel and/or subsequently and can reinforce and/or antagonize each other. Therefore, it is dicult to precisely attribute transcriptional functions to de®ned pathological processes or to identify those cellular responses triggered by individual transcription factors. Finally, as it is true for the majority of cellular responses, TF-triggered responses might coincidentally feed into both, adaptive-protective responses and unbalanced prodegenerative triggers.
Only few experimental paradigms can be considered as somewhat monofactorial such as axotomy (i.e. mechanical transection of nerve ®bers) and excitotoxic stimulation e.g. systemic application of kainic acid. In these cases, the primary insult ± i.e. axon transection and transmembranous excitation ± determine the neuronal response. In contrast, the delayed nonneuronal reaction such as in¯ammation, phagocytosis or scar formation are the consequence of neuronal degeneration, i.e. they do not substantially contribute to the primary neuronal response. Nevertheless, even the quasi`monofactorial' axotomy can be split into individual pathophysiological processes such as omission of target-derived trophic factors, structural damage of the axon and activation of Schwann cells leading to a release of various cytokines and chemokines.
The relation of AP-1 proteins and MAP kinases and their physiological functions For the analysis of AP-1 functions, it is mandatory to understand the upstream system of kinases which is essential for the induction and/or activation of the transcription factors. The AP-1 dimers are part of the transcriptional eector system of the ERK, JNK and p38 MAP kinases, i.e. AP-1 proteins ful®ll (some of) their functions in the context of MAP kinases. As with other kinase systems, the MAP c-Jun/AP-1 and neurodegeneration T Herdegen and V Waetzig kinase integrate intra-and extracellular signals and reinforce or antagonize the (parallel) information transfer of other signal-transduction pathways (Ichijo, 1999 ; see also Rincon et al., this issue). Therefore, the understanding of the eector pro®le of MAP kinases provides crucial insight into the function of AP-1 proteins. We have to emphasize, however, that AP-1 proteins can modulate gene transcription independent of preceding MAP-kinase activation and, vice versa, MAP kinases have a wide range of action by post-translational modi®cation of nonnuclear substrates.
The c-Jun/JNK-axis
It is accepted knowledge that the transcriptional action of c-Jun strictly depends on its phosphorylation of the serine 63 and 73 residues (Gupta et al., 1996; Kallunki et al., 1996) . Consequently, the study of JNKs in the brain enlightens the contextual understanding of their nuclear substrates c-Jun and (in c-Jun heterodimers) JunD (Kallunki et al., 1996 , Figure 1 ). However, data are also available on calciumtriggered c-Jun activation independent of both, the phosphorylation of N-terminal serines 63/73 and the (Cruzalegui et al., 1999; Rizzo et al., 1999) , and in PC12 cells, phosphorylation of the cJun serine residues 63 and 73 was found to be regulated by ERKs (Leppa et al., 1998) . Besides these residues, other amino acids might be relevant for c-Jun activation since the exchange of threonine residues at position 91 and 93 to phosphate-mimicking aspartic acid residues enhances the`gain of function' of the serines 63 and 73 (Musti et al., 1997) . The presence of JNK-interacting proteins (JIPs), positive as well as negative regulators of JNK-mediated c-Jun phosphorylation (Dickens et al., 1997) can channel JNK signaling away from c-Jun as shown in cerebellar granule cells where an increase in nuclear JNK activity parallels a decrease in c-Jun phosphorylation and expression (Coey et al., 2000) . Finally, primary hippocampal/cortical neurons from c-JunAA mutants are protected against kainic acid-induced apoptosis inspite of unaltered JNK activity (Behrens et al., 1999) .
Physiological functions
In the adult mammalian brain, the three JNK genes are transcribed and are most likely present in their activated form (Carletti et al., 1995; Martin et al., 1996; Mielke et al., 2000; Schauwecker, 2000; under normal conditions, i.e. during the absence of any intentional stimulation. One prominent feature of the c-Jun/JNK-axis is their involvement in neuronal plasticity and memory formation: (i) JNKs are largely residing in neurites in vitro (Coey et al., 2000) and are retrogradely transported in neuronal axons in vivo (Fernyhough et al., 1999) , i.e. they act as signal molecules between the presynaptic terminal and the perikaryon; (ii) JNKs alter cytoskeletal functions by transcriptional regulation and phosphorylation of neuro®laments, tau proteins and microtubulins (Reynolds et al., 2000; Sadot et al., 1998) , and inversely (iii) by inhibition of glucocorticoid receptor transcriptional activity, c-Jun and JNKs are eectors of speci®c cell programs initiated by depolymerization of the cytoskeleton after con¯uency (Oren et al., 1999) , and similarly, c-Jun and JNKs are activated by microtubular disarray (Wang et al., 1998; Yujiri et al., 1999) ; on the other hand, con¯uency of PC12 cells drastically inhibited cJun phosphorylation by JNKs (Lallemand et al., 1998) . Taken together, the c-Jun/JNK-axis participates in the sensoring for cytoskeletal alterations; (iv) JNK3 phosphorylates the threonine at position 668 of the Alzheimer's disease amyloid precursor protein (APP) (Standen et al., 2001) with physiological functions such as eects on neuronal dierentiation; (v) JNKs receive transmembranous signals in microdomains (McDonald et al., 2000) ; and ®nally, (vi) JNKs initiate long-lasting genetic alterations by activation of TFs such as c-Jun, JunD or ATF-2 (Gupta et al., 1996; Kallunki et al., 1996) . This plethora of properties renders JNKs as perfect candidate molecules for memory formation. In fact, visual stimulation, exposure to a novel environment and generation of electro-convulsive seizures (an experimental paradigm for neuronal plasticity) activates JNK with N-terminal phosphorylation of c-Jun in the rodent brain Xu et al., 1997) . Interestingly, repetition of electro-convulsive seizures dramatically reduces their eectiveness for cJun phosphorylation in the presence of ongoing JNK activation . This habituation of the transcriptional processes indicates the presence of regulatory mechanisms for JNK-triggered c-Jun activation which are activated following lasting and/or repetitive stimulation underlying neuronal plasticity. It is important in this context that the glutamate receptor subunit 6 (GluR6, a member of the kainate receptor family) mediates seizure activity and spontaneous bursts (Telfeian et al., 2000) with reduced sensitivity to kainic acid in mice with GluR6 knockout (Mulle et al., 1998) . GluR6 transmission is coupled with JNK activation via PSD-95/SAP90 (a membraneassociated guanylate kinase), MLK2 and JIP (Sheng and Pak, 2000; Yasuda et al., 1999) Therefore, inhibition of JNKs or c-Jun might dissociate the essential axis between synaptic excitation and gene induction with resistance to seizure activity as seen following JNK3 knockout and c-JunAA knock in, but with the potential risk of inhibiting learning and memory formation.
Besides the adult nervous system, the c-Jun/JNKaxis has important functions for the maturation and dierentiation of neurons in vivo and in vitro. In cerebellar neurons, nuclear JNK activity from MKK7 complexes increases during neuritogenesis (in parallel with reduced c-Jun activity) (Coey et al., 2000) ; in PC12 cells, c-Jun and JNK contribute to neurite outgrowth (Kita et al., 1998; Leppa et al., 1998) . During postnatal development, the three JNK isoforms decline at various degrees in the brain (Carboni et al., 1998) , and these high perinatal levels indicate a role of JNKs during developmental neuroplasticity.
Variable activition of c-Jun and JNKs: questionable reliability
The expression and inducibility of individual JNK proteins, and in particular of their splice variants, however, under normal conditions and following patho-physiological stimuli are not yet resolved. This is true for in vivo and in vitro systems (Table 1) . The data are also diering on the intracellular distribution of JNKs as well as on the N-terminal phosphorylation of c-Jun: (i) There are studies reporting a weak and limited distribution of JNK1 in the brain which is also absent in the hippocampus (Carboni et al., 1998) while others describe a high JNK1-IR level which parallels that of JNK3 and a substantial basal JNK1 activity in the hippocampus . Inversely, information on strong and widely distributed JNK2 mRNA signals (Carboni et al., 1998) is in contrast to publications of low level JNK2-IR .
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(ii) The intranuclear presence of JNKs under basal conditions and the nuclear translocation of JNKs following stress (with subsequent phosphorylation of c-Jun and/or JunD) are further issues of controversial observations: Under basal conditions, JNK3-IR was detected in the cytoplasm (Martin et al., 1996) , whereas JNK1-IR was found in the cytoplasm and the nucleus (Schauwecker, 2000) or in the cytoplasm and the dendrites or only in the nucleus (Oo et al., 1999) . Visualization of phosphorylated JNK1+JNK2 immunoreactivity (p-JNK-IR) yielded a complete absence in untreated gerbils, and a nuclear p-JNK-IR following ischemia in the hippocampus (Sugino et al., 2000) . Diering observations exist on the absence or presence (Schauwecker, 2000) of phosphorylated c-Jun in the dentate gyrus, an area with high constitutive expression of c-Jun. Following systemic application of adriamycin, JNK1 is translocated into the nucleus without alteration of the total JNK1 content in dorsal root ganglia, and in these cells, JNK1 and phosphorylated c-Jun are concentrated in nuclear domains enriched in splicing factors and perichromatin ®brils (Pena et al., 2000) . Kainic acid raised the JNK1-IR in the cytoplasm and the nucleus of hippocampal neurons based on a moderate increase in the 46 kDa JNK-fraction (Schauwecker, 2000) , whereas MPTP provoked a moderate increase in the 54 kDa JNK-fraction in the substantia nigra (Saporito et al., 2000) . (iii) Substantial contradiction exists on the alteration of the expression of JNKs following neuronal stress: Downregulation of JNK1 expression (Chihab et Overview of the expression and the activation of JNKs and their upstream regulators in the brain and in neuronal cells in vitro. : gives an increase, ; gives a decrease of expression and/or activity; = marks no signi®cant alteration
Oncogene c-Jun/AP-1 and neurodegeneration T Herdegen and V Waetzig al., 1998) and immunoreactivity (Ferrer et al., 1997) is opposed to enhanced JNK1-IR (Schauwecker, 2000) and an increase in JNK1 activity in the hippocampus following kainic acid excitotoxicity and fetal hypoxia. JNK1 expression was upregulated in the substantia nigra compacta following striatal lesion (Oo et al., 1999) , whereas transcription of all three JNK isoform mRNAs did not change following severe stress in neural cell lines . (iv) Data based on the determination of JNK activity demand critical interpretation: Firstly, immunocomplex assays might display JNK autophosphorylation rather than JNK-triggered phosphorylation of the substrate (mainly GST-c-Jun) . Secondly, analysis of the activity of individual JNK-isoforms are impeded by lack of speci®c antibodies. Thirdly, neuronal degeneration with the induction of one JNK isoform (e.g. JNK3) in the presence of high basal activity of other isoforms (e.g. JNK1 and JNK2) does not simply argue for a speci®c neurodegenrative role of the induced isoform (Namgung and Xia, 2000) .
The reasons for these divergent ®ndings at mRNA and protein levels as well as in immunocytochemistry are not clear. At least for immunocytochemistry, most reports had not been subjected to critical analysis of immunoreactivities. JNKs are highly conserved essential mediators of cellular information transfer and responses. Therefore, it is doubtful whether JNKs operate with such an individual cell-type-dependent and stimulus-dependent pattern of transcription, translation and intracellular distribution. More likely, activation of JNKs might be minutely modulated iǹ microdomains' depending on the association with scaold regulators and upstream kinases. This demands speci®c non-crossreacting tools. Indeed, the recent analysis of intraneuronal JNK distribution and activation in cultured cerebellar granule cells has provided evidence like the existence of dierent JNKpools de®ned by upstream kinases MKK4 and MKK7 and the JIP scaold protein, with each pool dierentially activated following stress and maturation (Coey et al., 2000) . Finally, the paradigm of JNKs translocalization into the nucleus in dependence on their activation has been questioned by the observation that glucocorticoids inhibit the TNFa-induced phosphorylation of JNKs, and even enhances their nuclear translocalization (Gonzalez et al., 2000) .
c-Fos/ERK-axis
In contrast to the c-Jun/JNK-axis, the control of junB and c-fos induction and the activation of their proteins by post-translational modi®cations in the brain is less clear. Reports on c-Fos activating kinases (Deng and Karin, 1994) did not ®nd a subsequent echo, and the role of phosphorylation and dephosphorylation of cFos for DNA binding and activation of the polymerase II-complex in neurons has to be deduced from non-neuronal cells. The transcriptional regulation of cfos is mediated by ERKs with subsequent activation of the SRF/TCF complex; members of the TCF complex, such as Elk-1, are expressed and regulated in the adult brain including alteration in intraneuronal distribution (Sgambato et al., 1998) . ERKs are supposed to be protective-physiological counterplayers of the JNK/ p38 kinases (Xia et al., 1995) and are activated following numerous physiological and pathophysiological stimuli.
Activation of the FosB protein is strictly dependent on the phosphorylation of C-terminal serine residues by (a) not yet de®ned kinase(s) distinct from the known ERKs and JNKs (Skinner et al., 1997) .
Role in neurodegeneration
The c-Jun/JNK-axis Pro-degenerative ®ndings From all AP-1 proteins, the c-Jun protein is the best studied member concerning the putative roles in the context of neurodegeneration and neuroprotection. c-Jun and its activating JNKs have been determined as functionally synergistic eectors in neuronal cell death: knockout of JNK3 and mutation of the serine residues 63 and 73 into nonphosphorylable alanins (so called c-JunAA mutant) prevent kainic acid induced neuronal death in the hippocampal CA3 region (Behrens et al., 1999; . The elevated resistance to kainic acid indicates that JNK knockout and c-JunAA knock in (Behrens et al., 1999) have profound in¯uence on the development of de®ned pre-existing structures which realize neuronal excitation.
Transfection of sympathetic neurons with wildtype c-Jun (Ham et al., 1995) or with MEKK1 (and subsequent activation of JNK and c-Jun) (Eilers et al., 1998) induced apoptosis even in the presence of NGF, whereas cell death was prevented by transfection with dominant negative JNK1 (Eilers et al., 1998) . Numerous publications report on coincident activation of c-Jun and JNK during (apoptotic) degeneration of neurons in vivo and in vitro (Ferrer et al., 1997; Harada and Sugimoto, 1999; Ikeuchi et al., 1998; Levresse et al., 2000; Martin-Villalba et al., 1999; Mielke and Herdegen, 2000; Oo et al., 1999; Ozawa et al., 1999; Saporito et al., 2000; Virdee et al., 1997) . As a novel player of the c-Jun/JNK-axis, the apoptosis signalregulating kinase 1 (ASK1) appears to initiate the harmful functions of JNKs (Kanamoto et al., 2000; Nakahara et al., 1999) .
Finally, a set of experiments has demonstrated that inhibition of MLKs by CEP-1347 with subsequent inhibition of activation of JNK and c-Jun provides robust neuroprotection (Maroney et al., 1998; Saporito et al., 2000) . At present, molecules of this group of indirect JNK inhibitors undergo phase II trial, and this study aims at attenuating the progression of Parkinson's disease.
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These ®ndings, which underly the reputation of cJun and JNK as neuronal killers, have to be strictly set into the pathophysiological context and must not be generally misused as negative characteristics of these molecules for several reasons. Firstly, the expression and activation of c-Jun and JNK in the mammalian adult brain in the absence of any harmful stimulus or under neuroregenerative conditions as well as in neural cells cultures during dierentiation clearly suggest important physiological-protective roles for these molecules. Secondly, the dramatic attenuation of hippocampal CA3 neuronal death by JNK3 knockout (but not by JNK2 knockout and JNK1 knockout) and c-JunAA mutation (Behrens et al., 1999) following kainic acid excitotoxicity was observed in mice with a substantial C57/BL6 genetic background ± this strain, however, is explicitly resistant against kainic acid-triggered hippocampal death (Schauwecker, 2000; Steward et al., 1999;  Herdegen et al., unpublished observations), i.e. similar as with wild type C57/BL6 mice, the mutants should not undergo neuronal cell death and the`rescue' of the mutants might rather reveal natural resistance than neuroprotection mediated by genetic manipulation. These ®ndings summarised above raise several questions:
(i) The substrate speci®city is unclear which underlies the selective neurodegenerative eect of JNK3 in the hippocampus, an area with coincident expression (Carboni et al., 1998) and activity Mielke et al., 1999) of JNK1 and JNK2. One explanation lies in the individual expression of JIPs, a group of activators and inhibitors of JNKs with dierent anities for the individual JNKs (Kim et al., 1999; Yasuda et al., 1999) . (ii) A similar extent of hippocampal protection by JNK3 ko and by c-JunAA mutation (Behrens et al., 1999) and the respective lowering eect on seizure-related behavior following kainic acid but not after PTZ suggest that cJun is the mediator of JNK3 neurodegeneration.
In contrast, the analysis of the N-terminal phosphorylation of c-Jun and JNK activation following kainic acid in C57/BL6 mice has revealed the dissociation of this activation since increased phosphorylation of c-Jun could be linked with resistance to death, whereas JNK1 activity was associated with impending death (Schauwecker, 2000) . Moreover, the lasting immunoreactivity of phosphorylated JNK1+2 in the surviving CA3 gerbil hippocampus following ischemia (Sugino et al., 2000) does not support the simplifying concept of mere harmful functions by activated JNKs in the hippocampus. (iii) Apart from the hippocampus, no data are available to which extent the knockout of JNKs alters the c-Jun expression and phosphorylation. Thus, we do not know whether the activation of cJun downstream from JNK3 is restricted to the hippocampal CA1 sub®eld or whether the activation of c-Jun by JNK3 realizes the degenerative programs in a broader operative range. (iv) The N-terminal stretches comprising the phosphoacceptor sites are very similar in JunD and cJun (Kallunki et al., 1996) . This fact gives rise to the following scenario: c-Jun serves as a docking site for JunD (Kallunki et al., 1996) enabling JNKs to phosphorylate the JunD protein in c-Jun or c-JunAA containing heterodimers. In this case, the pattern of phosphorylation is congruent with the distribution of c-Jun but it derives from JunD. Still, it cannot be suciently excluded that the anti-phospho-c-Jun antibodies do not recognize phosphorylated JunD.
The function of c-Jun and JNKs as degenerativeapoptotic eectors is strictly dependent on the context of pathophysiological processes. As a representative example, retinal ganglion cells from E12,5 c-jun nullizygous mice do not exhibit programmed cell death when transplanted as xenografts in newborn rats (Herzog et al., 1999) .
The eector molecules What are the eectors of c-Jun mediated death? The apoptotis-realizing target genes of c-Jun/AP-1 are not well de®ned. The transcriptional control of the ®rst line candidates such as Fas ligand Kolbus et al., 2000) , TNFa (Falvo et al., 2000) cyclin D1 (Bakiri et al., 2000; Timsit et al., 1999) p53 (Kirch et al., 1999) by c-Jun is questioned by reports that these eectors are independently regulated of c-Jun/JNK or are not involved in neuronal apoptosis (Low et al., 1999; Napieralski et al., 1999; Small et al., 1999) . Beyond direct transcriptional activation of endogenous neuronal killer proteins as it is likely for the kainic-acid induced hippocampal death (Behrens et al., 1999; Yang et al., 1997) , pro-degenerative eects of c-Jun can be exerted by transcription of genes which enhance the pathological stress as demonstrated by the following examples.
(i) In immune cells, dierentiation and the production of cytokines and/or their corresponding receptors is co-modulated by JNKs (Sabapathy et al., 1999; Yang et al., 1998) , and this might also be true for microglia, the resident brain immune cells. Numerous observations report on neurodegenerative eects by (abundant) cytokine production (Raivich et al., 1999) . (ii) The tissue plasminogen activator (tPA) is a serine protease which is essential for ®brinolysis, but it is also involved in neuronal death and excitotoxicity (reviewed by Gingrich and Traynelis, 2000) . The basal and PMA-stimulated expression of the plasminogen-activator inhibitor 1 (PAI-1), an endogenous counterpart of tPA, is under the control of c-Jun homodimers (Arts et al., 1996) . Thus, it is conceivable that the omission of c-Jun dependent expression of the tPA-inhibitor in JNK knockout mice or c-JunAA mutants leads to the Oncogene c-Jun/AP-1 and neurodegeneration T Herdegen and V Waetzig removal of the endogenous tPA-`brake' with degeneration of the brain parenchyma following ischemia. Consistantly, knockout of the PAI-1 gene enlarges the cerebral infarct area after transient MCA occlusion (Wang et al., 1998) . Such a pathomechanism might explain our ®nding that JNK knockout does not diminish the size of infarct following MCA occlusion (unpublished observation). The concept of a c-Jun/JNK-triggered PAI-1/tPA-interplay, however, does not hold true for the observation that mice de®cient in tPA are virtually resistant to kainate-induced seizure with attenuated activation of microglia (Tsirka et al., 1995) . In this context, we have to consider the expression of matrix metalloproteinases (e.g. MMP-1, MMP-9) (Xu et al., 2001) which can trigger in¯ammatroy processes in the brain following injury.
Finally, direct evidence is lacking whether the degenerative eects of c-Jun/AP-1 in the adult brain are additionally realized beyond the transcription of genes e.g. by putative inhibition of other TFs, such as steroidhormone-ligand-complexes (see also Chinenov and Kerppola in this issue). It is conceivable that c-Jun interferes with gonadal steroids which can act as promoting factors in axonal regeneration (Jones, 1993) .
The promiscous expression of the c-Fos protein, and the remaining AP-1 proteins
The expression pattern of c-Fos, the main representative of the Fos family, is well characterized following numerous neurodegenerative events. Its putative pathogenic role, however, is still enigmatic. Null mutation of the c-fos gene attenuates the kindling development and kindling-induced structural plasticity (Watanabe et al., 1996) , and this phenotype resembles the resistance to kainic acid seizures following JNK3 knock-out and cJunAA mutation (Behrens et al., 1999; Yang et al., 1997) . Thus, similar to the c-Jun/JNK-axis, the expression of c-Fos is involved in excitotoxicity (depending on dimerization with c-Jun?). In further comparison with c-Jun, the insight into functions of cFos is much less clari®ed. (i) There is still no marker available which indicates the transactive form of c-Fos corresponding to the N-terminal phosphorylation of cJun. (ii) Very often, pathological stimuli can be regarded as enhanced physiological stimuli; in consequence, pathological input should include the activation of both, physiological responses and pathologicaldegenerative programs. Thus, expression of c-Fos or JunB can represent the physiological and/or the degenerative part of the stimulus. (iii) Following some degenerative processes with selective induction of c-Jun (e.g. axotomy), the absence of c-Fos indicates an active suppression rather than the mere lack of the inducing input (reviewed by Herdegen et al., 1997) and the possibility of c-Fos degradation by c-Jun (Tsurumi et al., 1995) . (iv) In contrast to JNK pathways, the upregulation of ERKs cannot be linked to neuronal degeneration, but rather to physiological programs and neuroprotection (Xia et al., 1995) . Inhibition of ERK, however, does not worsen the ischemic progress in the gerbil (Sugino et al., 2000) . On the other hand, push of calcium/cAMP pathways with activation of the CRE c-fos promoter site (with coincident activatioin of ERKs?) can be involved in pathological programs following calcium overload. (v) Degeneration can be regarded as a lasting/chronic harmful stimulus ± the expression of c-Fos protein, however, often habituates to repetitive stimuli (Hsieh et al., 1998) .
Similar as with c-Fos, the data on the expression of JunB, JunD, FosB and Fra proteins are more or less correlative, but nevertheless linked to processes involved in regeneration and degeneration: lasting FosB/ JunD-complexes re¯ected the adaptive neuronal responses in the denervated striatum following MPTP injection , Fra-2-IR persisted in neurons surviving an ischemic insult (Pennypacker et al., 2000) . Dierential eects of Jun proteins have been described for the regulation of hippocampal NGF expression following limbic seizures with participation of JunD in activation and of JunB in suppression (Elliott and Gall, 2000) , and JunD might exert a major role in NGF production with variable AP-1 partners such as c-Fos or phosphorylated Fra-2 (Boss et al., 2001) .
Role of the c-Jun/JNK-axis in neuroprotection
Besides physiological functions in the`normal' brain, cJun and its upstream activators JNKs are also involved in processes underlying neuroregeneration or neuroprotection. Conditioning ischemia with the rescue of hippocampal neuronal death is linked to the selective induction of c-Jun in the surviving CA1 neurons which otherwise die in the absence of c-Jun (Sommer et al., 1995) . The lasting expression of c-Jun in successfully regenerating neurons including intrinsic central neurons such as retinal ganglion cells or thalamic neurons (Vaudano et al., 1998) , the enhanced re-induction of cJun following spinal cord transection even months after the previous injury (Houle and Ye, 1999) or the protection of ischemic retinal ganglion cells by intravitreal BDNF in the presence of c-Jun (Kurokawa et al., 1999) suggest functions of c-Jun in survival and regeneration rather than for axotomy-triggered degeneration (reviewed in detail by Herdegen et al., 1997) . In PC12 cells, neurite formation has been shown to be dependent on the ASK1-JNK pathway, Rac-JNK pathway (Kita et al., 1998) or MEK1-c-Jun pathway (Leppa et al., 1998) . This model, however, cannot be simply transferred to axonal re-growth in the nervous system, since numerous molecules including inhibitors of mitosis are eective unspeci®c inducers of neuritogenesis.
Recent ®ndings have set the expression and activation of c-Jun/JNK into a novel protective-regenerative context. The c-Jun expression following axon-disruption can be mimicked by colchicine, a microtubulec-Jun/AP-1 and neurodegeneration T Herdegen and V Waetzig interfering agent, even when the neuron-target-axis is morphologically intact (Leah et al., 1991) . Full-length MEKK1 (i.e. not cleaved by caspase-3) with downstream activation of JNK protects embryonic stem cells against apoptosis caused by microtubule toxins (Yujiri et al., 1999) . Thus, axotomy-triggered expression of cJun and retrograde transport of JNK Kenney and Kocsis, 1998) most likely function as a sensor for axonal integrity. The action of c-Jun is supported by the re-appearance of ATF-2 in regenerating neurons (Kreutz et al., 1999) , whereas the early and rapid disappearance of ATF-2 is a feature of neuronal injury . Finally, the antiapoptotic molecule Bcl-3 has been identi®ed as a neuroprotective eector of c-Jun; interestingly, apoptosis caused by IL-4 deprivation induces downregulation of c-Jun and Bcl-3, but up-regulation of cFos (Rebollo et al., 2000) . Besides c-Jun, the family member JunD can confer protection by antagonisation of the p53 expression; in consequence, c-Jun might be involved in neuroprotection as a docking molecule for JNKs allowing these kinases to activate JunD (Kallunki et al., 1996) .
Pathological responses and AP-1 expression following intentional stimulation: the problem of linkage
Strictly speaking, the visualization of AP-1 expression allows only the conclusion that an intentional stimulus (which usually starts a complex cascade of various pathophysiological refunctions) causes the de novo synthesis of AP-1 proteins. The critical issue of the meaning of AP-1 expression for the cellular/neuronal reaction can be exempli®ed by the persistance of c-Jun in axotomized neurons ± its lasting expression for weeks in surviving neurons or until the fragmentation of dying neurons allows a bipartite conclusion: (i) cJun is involved in the regenerative-protective eorts of injured neurons which last until realization of death by unbalanced degenerative programs or until the recovery with/without structural regeneration; (ii) c-Jun is involved in degenerative genetic programs which last until the`successful' (apoptotic) termination or which come to an end with the onset of the neuronal recovery by protective-regenerative programs. And this observation is also true for both, the N-terminal phosphorylation of c-Jun and the activation of JNK .
Regulation of pathological-degenerative functions of the c-Jun/JNK-axis in the brain
The data on the role of c-Jun under physiological and pathological conditions provoke the essential question: which molecular mechanisms determine the tripartite functional transition of c-Jun from a physiological player to a neurodegenerative eector or to a modulator of neuroregeneration? JNKs form a central, but not exclusive, role for the c-Jun activation, which is also true for the nervous system. Therefore, we review the regulation of c-Jun with particular focus on its upstream N-terminal activators, JNKs. Several components can be de®ned for the regulation of the c-Jun/ JNK-axis ( Figure 1 ; Table 2 ):
(i) Induction. The classi®cation of AP-1 proteins as immediate-early genes (IEGs) re¯ected their rapid de novo synthesis following serum deprivation or TPA stimulation (Almendral et al., 1988) . The rather uniform expression is based on similar DNA response elements with the primarily functional designation of the TPA response element (TRE). This temporally staggered, but nevertheless congruent, AP-1 expression pattern is visible at mRNA and protein level following transynaptic stimulation e.g. following kainic acid or noxious stimulation (Beer et al., 1998; Herdegen and Leah, 1998) . One essential particularity of c-Jun is its selective induction in the absence of other AP-1 proteins. Recently, we have de®ned the distal jun2 (and to a lesser extent the proximal jun1) response element as regulatory elements for ATF-2 and c-Jun mediated c-jun induction in the brain. Besides ATF-2 and c-Jun, the p38 pathway with the transcription factor MEF2C has emerged as a novel regulator of the c-jun induction (Han et Marinissen et al., 1999) ; interestingly, MEF2C can mediate neuronal survival and neurite elongation during development (Mao et al., 1999) . The down-regulation of ATF-2, a nuclear substrate of p38, is strictly coincident with c-Jun induction following neuronal injury and this might substantially change the competitive situation of p38 substrates e.g. with shift from ATF-2 to MEF2C phosphorylation with initiation of c-jun induction in the absence of ATF-2 and c-Jun.
(ii) Activation by N-terminal phosphorylation.
. Scaold proteins. The N-terminal phosphorylation is the crucial step in the transcriptional activation of c-Jun, but the operative range of JNKs and ERKs and the c-Jun amino residues involved has still to be de®ned. Nevertheless, the activation of JNKs might be the most relevant step in the instrumentalization of c-Jun as a prodegenerative eector. Therefore, the regulation of JNKs deserves particular attention. By complexation with distinct scaold proteins, JNKs are coupled to individual signal-transduction units with dierent upstream activators. The group of JNK-interacting proteins (JIPs) selectively mediates signaling by the mixed-lineage kinase (MLK)4MAP kinase kinase 7 (MKK7)4JNK pathway, and their oligomeric complexes accumulate in peripheral cytoplasmic projections (Yasuda et al., 1999) ; interestingly, MLK2/3 can associate with the GluR6-PSD95 scaolds (Liu YF, oral communication) , and the activation of JNKs by MLK2 partially mediates apoptosis by polyglutamine-expanded huntingtin (Liu et al., 2000) . Apart from renal jip1 mRNA, the JIP1-3 proteins are highly expressed in the brain (Kim et al., 1999) with cytoplasmic and axonal-presynaptic distribution (Pellet et al., 2000) , and complexes with MLK2 and activated JNK have been found along microtubules in ®broblasts . Expression of JIPs can be enhanced at a transcriptional level following ischemia (Hayashi et al., 2000) , neuronal denervation (Anguelova et al., 2000) or inhibition of JNK (Levresse et al., 2000) with an immediate impact on JNK activation, since the overexpression of JIPs relative to JNKs blocks JNK functions (Ferrell, 2000) . The JNK-associated protein 1 (JSAP1), which is synonymous to JIP-3 and displays a preference for JNK3 (Ito et al., 1999) , antagonizes the activation of ERKs by inhibition of the Raf-1 mediated MEK1 phosphorylation (Kuboki et al., 2000) . Finally, the û-arrestin 2 protein has recently been identi®ed as a scaold for JNK3 in the murine brain which mediated the cytosolic retention of JNKs and the activation by ASK1 (McDonald et al., 2000) . In principle, scaolds have the potential to facilitate signaling ± but¯uctuations of the pathway components will inevitably lead to a less ecient signal transfer. The facilitation of signal response by scaolds ultimately leads to an ultrasensitivation with potential Hill coecients of more than 10 (Ferrell, 2000) . Thus, an increase in expression and activation of individual cascade members might be without relevance in the absence of concomitant stocheometric alterations in scaold proteins or decrease ecacy of signal transduction by disturbance of the balance of scaold complexes. . Antagonistic phosphatases. Besides inhibition of phosphorylation by scaolds, activation of JNK can be terminated by the speci®c MAP kinase phosphatases 3/6 (MKP3/6) (Muda et al., 1996) and unspeci®cally by MKP1 or MKP2 (Keyse, 1998) . Recently, we have shown an increase of nuclear MKP1 following transection of central nerve bundles in surviving mamillary neurons, but not in dying neurons of the substantia nigra compacta . On the other hand, downregulation of MKPs constitutes an eective step for the activation of JNKs as it has been reported following protein-damaging conditions (Meriin et al., 1999) . (iii) Parallel activation of agonistic or antagonistic signal cascades. Numerous signal-transduction cascades have the potential to activate JNKs, and ± in the case of nuclear translocation ± with subsequent activation of c-Jun. In the context of c-Jun/JNK functions activated during neurodegenerative processes, the in¯uence of the three activating cascades p38-ATF2/MEF2C, ASK1-JNK and Akt-JNK deserves particular interest. First of all, activation of p38 can enhance the induction of c-jun by phosphorylation of ATF-2 or MEF2C; furthermore, the phosphorylation of ATF-2 could interfere with the competition of cJun for binding to or being phosphorylated by JNKs (Gupta et al., 1996) . Importantly, inhibition of p38-catalyzed substrate phosphorylation substantially protects against ischemic injury in the gerbil (Sugino et al., 2000) .
Secondly, ASK1 was colocalized with activated JNK or activated p38 in apoptotic cells following spinal cord injury (Nakahara et al., 1999) . Microtubular disarray, a putative feature of neuronal degeneration, induced c-Jun dependent transcription via JNK and synergistic but parallel activation of ASK1 (Wang et al., 1998) . ASK1 keeps the position of a master switch for activating both, p38 and, to a lesser extent, JNK with speci®c or synergistic functions. Thus, ASK1 triggers neurite extension in PC12 cells with downstream phosphorylation of JNK and p38; on the other hand, ASK1 is a crucial modulator of NGF withdrawal-induced apoptosis in PC12 cells and superior cervical ganglia with activated c-Jun/JNK-axis and p38 (Kanamoto et al., 2000) . In contrast to ASK1, the Akt kinase (also called protein kinase B) which acts downstream of phosphatidylinositol-3-kinase (PI3-K), distinctly inhibits the activation of JNK and cc-Jun/AP-1 and neurodegeneration T Herdegen and V Waetzig
Jun and protects against neuronal apoptosis (Levresse et al., 2000) . The synergistic and antagonistic interplay of dierent signal cascades is nicely exempli®ed in trigeminal neurinoma cells (Marushige and Marushige, 1999) : apoptosis was rapidly induced when the activation of JNK was coupled with the inhibition of PI3-K/Akt, and the induction was further enhanced by parallel inhibition of ERK; rapid apoptosis occurred when the JNK activation was coupled with p38 inhibition, and this was potentiated by inhibiting PI3-K/Akt; the concomitant inhibition of ERK and activation of Akt induced apoptosis without JNK activation, even though with a considerable delay (Marushige and Marushige, 1999) .
Conclusions
Neurodegenerative events with regenerative eorts and/ or apoptotic destruction induce AP-1 proteins in highly complex temporospatial patterns. In terms of neurodegeneration, we have to dierentiate between AP-1 functions in neuronal cells and in non-neuronal cells which in turn harmfully aect neurons. Considering the complex interplay of various reinforcing and/or antagonizing activators and inhibitors of AP-1 functions in the intra-and extracellular compartments, only few ®ndings can be attributed to AP-1 proteins and their upstream activators de®ning a role for degenerative and regenerative eorts. In the majority of experiments and observations, the AP-1 transcription factors play their part in the orchestration of the ®ne functional tuning underlying the neuronal plasticity.
Besides clearly de®ned neuronal responses exclusively or mainly triggered by c-Jun and the JNKs upstream, c-Jun and JNKs might act as stand-by molecules which help to implement decisions as conditio sine qua non. The potentially relevant physiological functions of the c-Jun/JNK-axis might limit the use of antagonists as a novel strategy for the treatment of neurological disorders. 
